Poseida Therapeutics, Inc. Common Stock

Go to Poseida Therapeutics, Inc. Common Stock Website

$9.50

(%)
Live
Previous Close

$9.5

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Roche has completed the acquisition of Poseida Therapeutics, a clinical-stage biopharmaceutical company, through a tender offer and subsequent merger. Poseida's pipeline includes investigational allogeneic CAR-T cell therapies and in vivo genetic medicines.

Related tickers: PSTX.

Read Full Article

Roche has commenced a tender offer to acquire all outstanding shares of Poseida Therapeutics for $9.00 per share in cash, plus a contingent value right of up to $4.00 per share. The transaction is subject to customary closing conditions and regulatory approvals.

Related tickers: PSTX.

Read Full Article
Trending Tickers

Please sign in to view